Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience
1Hepatobiliopancreatic Surgery and Transplantation Department, Hospital Clínic Barcelona, Barcelona, Spain, 2Organización Nacional de Trasplantes (ONT), Madrid, Spain, 3Department of Nephrology., University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, 4Department of Surgery, University Hospital Marques de Valdecilla, University Cantabria, Santander., Santander, Spain, 5Department of General, Visceral and Transplantation Surgery., Clinic and University Hospital Virgen de la Arrixaca. IMIB-ARRIXACA. Murcia., Murcia, Spain, 6Department of Surgery, Hospital Regional de Málaga. Málaga., Málaga, Spain, 7Department of Nephrology., Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, 8Department of Surgery, Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, 9Department of Surgery, University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, 10Hepato-Pancreatico-Biliary Surgery and Transplant Unit, La Fe University Hospital. Valencia, Valencia, Spain, 11Department of Surgery, Hospital Universitario Reina Sofía. Córdoba, Córdoba, Spain, 12Department of Nephrology., Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, 13Department of Surgery, Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, 14Renal Transplant Unit, Hospital Clínic Barcelona, Barcelona, Spain, 15Coordination Department, Hospital Clínic Barcelona, Barcelona, Spain
Meeting: 2021 American Transplant Congress
Abstract number: LB 91
Keywords: Donors, non-heart-beating, Graft survival, Pancreas transplantation, Surgical complications
Topic: Clinical Science » Pancreas » Pancreas and Islet: All Topics
Session Information
Session Name: Pancreas and Islet: All Topics
Session Type: Poster Abstract
Session Date & Time: None. Available on demand.
Location: Virtual
*Purpose: To report on the Spanish Pancreas Transplantation experience in controlled donation after circulatory death (cDCD) by analyzing the normothermic regional perfusion (NRP) and super-rapid recovery
*Methods: Data from January 2015 to December 2020 were analyzed regarding pancreas transplantations using cDCD donors
*Results: Some 471 pancreas transplants were performed, 20 being from cDCD donors.NRP was used in 18 pancreases.The median functional WIT was 10 (7-15.5) min. NRP was run for 113.5 (91.5-134.5) minutes. Pancreas cold ischemia was 412.5 (330-636.7) minutes. Surgical complications were present in 70% of cases.Two patients of the NRP group presented with primary pancreas graft non-function. After a median follow-up of 13.6 (5.6-36.4) months, the 1 and 5-year overall pancreas survival rate was 85% for the whole series, 83.3% for NRP group and 100% for SSR group.Overall 1 and 5-year patient survival was 94.7%, with no group differences
*Conclusions: To date, this is the largest series describing the use of postmortem NRP in cDCD pancreas transplantation, providing competitive results in terms of graft/patient survival
To cite this abstract in AMA style:
Ferrer-Fàbrega J, Muñoz R, Ruiz J, Casanova D, Sánchez-Bueno F, Pérez-Daga J, Fernández-Rivera C, Gómez M, Castillo F, López-Andújar R, Maupoey J, Briceño J, Sánchez-Hidalgo J, Arjona Á, Álvarez A, Alarcó A, Bravo A, García R, Rull R, López-Boado M, Ventura-Aguiar P, Diekmann F, Paredes D, García-Valdecasas J, Fuster J, Fondevila C, Domínguez-Gil B. Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/controlled-donation-after-circulatory-death-pancreas-transplantation-in-spain-initial-experience/. Accessed May 12, 2025.« Back to 2021 American Transplant Congress